Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about disclosure

26 Aug 2022 Evaluate

Aurobindo Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 25, 2022 for Kambam Kirthi Reddy.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1841.00
Dr. Reddys Labs. 1355.00
Cipla 1375.20
Lupin 2013.30
Zydus Lifesciences 1238.00
View more..